Jenburkt Pharmaceuticals Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 308.193 million compared to INR 315.646 million a year ago. Net income was INR 38.767 million compared to INR 46.165 million a year ago. Basic earnings per share from continuing operations was INR 8.45 compared to INR 10.06 a year ago. For the full year, total revenue was INR 1,136.027 million compared to INR 1,231.092 million a year ago. Net income was INR 165.024 million compared to INR 148.696 million a year ago. Basic earnings per share from continuing operations was INR 35.96 compared to INR 32.4 a year ago.